Pricing Log in Create free account

Immix Biopharma, Inc. (IMMX) vs Obsidian Therapeutics, Inc (OBX)

Immix Biopharma, Inc. and Obsidian Therapeutics, Inc are both Biotechnology companies. Immix Biopharma, Inc. and Obsidian Therapeutics, Inc are of similar size ($596.9M and $593.0M). Across the 4 metrics below, Obsidian Therapeutics, Inc leads on 3 and Immix Biopharma, Inc. on 1.

Valuation

Metric IMMX OBX Biotechnology median
P/E n/m — 10.60
P/S n/m n/m 9.40
P/B 2.23 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (10.97%) — (32.88%)
Free cash flow yield (7.64%) 0.00% (23.13%)

Profitability

Metric IMMX OBX Biotechnology median
Gross margin — — 68.51%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% — 0.00%
Return on equity (34.18%) — (51.96%)
Return on assets (31.34%) — (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IMMX OBX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (17.11%) (11.60%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric IMMX OBX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 25.13 4.21 4.97
Net debt to EBITDA 3.39 0.77 1.01

Dividend

Metric IMMX OBX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IMMX OBX Biotechnology median
Market cap 596.90m 593.02m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack